Literature DB >> 25448311

Association of lung function with coronary heart disease and cardiovascular disease outcomes in elderly: the Rancho Bernardo study.

Hwa Mu Lee1, Michael A Liu2, Elizabeth Barrett-Connor3, Nathan D Wong2.   

Abstract

INTRODUCTION: Lung function is inversely associated with coronary heart disease (CHD) and cardiovascular disease (CVD). We evaluated the prospective association of reduced lung function by spirometry and CHD or CVD events in older community-dwelling adults.
METHODS: We studied 1548 participants (mean age 73.6 ± 9.2 years, 42% males) from the Rancho Bernardo Study using age, sex, and risk-factor adjusted Cox regression to assess pulmonary function (FEV1, FVC, and FEV1/FVC ratio) as a predictor of CHD and CVD events followed for up to 22 years.
RESULTS: Of CVD risk factors, older age, male sex, current/past smoking, physical exercise (<3× a week), and prevalent CVD predicted an increased risk of CHD and CVD. Higher FEV1 and FVC were each associated with a decreased risk of CHD [HR 0.80 (0.73-0.88) for both FEV1 and FVC, per SD, p < 0.01] and CVD [HR 0.82 (0.74-0.91) for both FEV1 and FVC, per SD, p < 0.01]. Those in the lowest quartiles of FEV1 and FVC had hazard ratios of 1.68 (1.33-2.13) and 1.55 (1.21-2.00) respectively for CHD and 1.74 (1.34-2.25) and 1.49 (1.13-1.96) respectively for CVD (all p < 0.01, relative to those in the highest quartile). Similar findings were observed for CHD and CVD mortality. Sex- and age-stratified analyses showed the strongest associations for CHD and CVD events in women and in the oldest participants.
CONCLUSIONS: FEV1 and FVC are inversely associated with risk of future CHD and CVD events in older community-dwelling adults and may add to CVD risk stratification in the elderly.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Coronary heart disease; Epidemiology; Pulmonary function test

Mesh:

Year:  2014        PMID: 25448311      PMCID: PMC4254667          DOI: 10.1016/j.rmed.2014.09.016

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  26 in total

1.  Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial.

Authors:  D O Wilson; R M Rogers; E C Wright; N R Anthonisen
Journal:  Am Rev Respir Dis       Date:  1989-06

2.  Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study.

Authors:  K L Ebi-Kryston
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

3.  Respiratory risk factors and mortality: longitudinal studies in Washington County, Maryland.

Authors:  M S Tockman; G W Comstock
Journal:  Am Rev Respir Dis       Date:  1989-09

4.  The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trial.

Authors:  L H Kuller; J K Ockene; M Townsend; W Browner; E Meilahn; D N Wentworth
Journal:  Am Rev Respir Dis       Date:  1989-09

5.  Spirometric findings and mortality in never-smokers.

Authors:  P Lange; J Nyboe; M Appleyard; G Jensen; P Schnohr
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

6.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study.

Authors:  D J Hole; G C Watt; G Davey-Smith; C L Hart; C R Gillis; V M Hawthorne
Journal:  BMJ       Date:  1996-09-21

7.  Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease.

Authors:  A M Schols; J Slangen; L Volovics; E F Wouters
Journal:  Am J Respir Crit Care Med       Date:  1998-06       Impact factor: 21.405

8.  Peak expiratory flow and risk of cardiovascular disease and death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden.

Authors:  C Persson; C Bengtsson; L Lapidus; E Rybo; G Thiringer; H Wedel
Journal:  Am J Epidemiol       Date:  1986-12       Impact factor: 4.897

9.  Nutritional status and mortality in chronic obstructive pulmonary disease.

Authors:  K Gray-Donald; L Gibbons; S H Shapiro; P T Macklem; J G Martin
Journal:  Am J Respir Crit Care Med       Date:  1996-03       Impact factor: 21.405

10.  Effect of active and passive smoking on ventilatory function in elderly men and women.

Authors:  C Frette; E Barrett-Connor; J L Clausen
Journal:  Am J Epidemiol       Date:  1996-04-15       Impact factor: 4.897

View more
  15 in total

1.  Asthma Status and Risk of Incident Myocardial Infarction: A Population-Based Case-Control Study.

Authors:  Duk Won Bang; Chung-Il Wi; Eun Na Kim; John Hagan; Veronique Roger; Sheila Manemann; Brian Lahr; Euijung Ryu; Young J Juhn
Journal:  J Allergy Clin Immunol Pract       Date:  2016-05-04

Review 2.  The bidirectional relationship between chronic obstructive pulmonary disease and coronary artery disease.

Authors:  Ayham Daher; Michael Dreher
Journal:  Herz       Date:  2020-04       Impact factor: 1.443

Review 3.  Inspiratory muscle weakness in cardiovascular diseases: Implications for cardiac rehabilitation.

Authors:  Joshua R Smith; Bryan J Taylor
Journal:  Prog Cardiovasc Dis       Date:  2021-10-22       Impact factor: 8.194

4.  Spirometric impairments, cardiovascular outcomes, and noncardiovascular death in older persons.

Authors:  Carlos A Vaz Fragoso; Peter H Van Ness; Terrence E Murphy; Gail J McAvay
Journal:  Respir Med       Date:  2018-02-27       Impact factor: 3.415

Review 5.  Enhancing oxygenation of patients with coronavirus disease 2019: Effects on immunity and other health-related conditions.

Authors:  Ayman Mohamed; Motaz Alawna
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

6.  Late-Onset Asthma Predicts Cardiovascular Disease Events: The Wisconsin Sleep Cohort.

Authors:  Matthew C Tattersall; Jodi H Barnet; Claudia E Korcarz; Erika W Hagen; Paul E Peppard; James H Stein
Journal:  J Am Heart Assoc       Date:  2016-08-24       Impact factor: 5.501

7.  Association of lung function with cardiovascular risk: a cohort study.

Authors:  Bin Wang; Yun Zhou; Lili Xiao; Yanjun Guo; Jixuan Ma; Min Zhou; Tingming Shi; Aijun Tan; Jing Yuan; Weihong Chen
Journal:  Respir Res       Date:  2018-11-06

Review 8.  Role of increasing the aerobic capacity on improving the function of immune and respiratory systems in patients with coronavirus (COVID-19): A review.

Authors:  Ayman A Mohamed; Motaz Alawna
Journal:  Diabetes Metab Syndr       Date:  2020-04-28

9.  Low lung function and the risk of incident chronic kidney disease in the Malmö Preventive Project cohort.

Authors:  Suneela Zaigham; Anders Christensson; Per Wollmer; Gunnar Engström
Journal:  BMC Nephrol       Date:  2020-04-08       Impact factor: 2.388

10.  Birth weight and prematurity with lung function at ~17.5 years: "Children of 1997" birth cohort.

Authors:  Baoting He; Man Ki Kwok; Shiu Lun Au Yeung; Shi Lin Lin; June Yue Yan Leung; Lai Ling Hui; Albert M Li; Gabriel M Leung; C Mary Schooling
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.